Cannabis and Exercise: The Science

The intersection of cannabis and exercise has moved from taboo to a legitimate research area. The discovery that runner’s high is mediated by endocannabinoids rather than endorphins reframed how scientists think about the exercise-cannabis relationship. Meanwhile, professional athletes across multiple sports have publicly endorsed cannabis for recovery, and most major sports organizations have removed it from banned substance lists. This guide covers the science from molecular mechanisms to real-world athletic use.

The Endocannabinoid System and Physical Activity

The human body produces its own endocannabinoids — lipid-based neurotransmitters that activate CB1 and CB2 receptors. The two primary endocannabinoids are anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Both are produced “on demand” in response to neural activity and are immediately broken down by enzymes (FAAH breaks down anandamide; MAGL breaks down 2-AG) after they complete their signaling function.

Physical exercise is a potent trigger for endocannabinoid production. Multiple studies have documented significant increases in circulating anandamide levels during and immediately after sustained moderate-intensity exercise (particularly running, cycling, and swimming at 70–80% maximum heart rate). This surge in anandamide is now understood to be a key mechanism of exercise-induced mood improvement.

Runner’s High: Endorphins vs Endocannabinoids

The “endorphin hypothesis” of runner’s high — that beta-endorphin released during exercise produces the euphoric, anxiolytic effect — has been the standard explanation since the 1980s. It turns out this was incomplete.

A 2021 study by Fuss et al. published in the Proceedings of the National Academy of Sciences tested the hypothesis directly. Researchers trained mice to run, then administered runners a cocktail of blockers:

• When CB1 receptors were blocked (eliminating cannabinoid signaling), mice showed significantly reduced post-run anxiety reduction and reward — the two hallmarks of runner’s high
• When opioid receptors were blocked, the anxiety reduction and rewarding effects of running were not significantly impaired
• The critical molecular reason: anandamide (an endocannabinoid) is small enough to cross the blood-brain barrier; beta-endorphin is a large peptide that does not efficiently cross the barrier in exercise quantities

This does not mean endorphins play no role in exercise reward — they likely contribute to pain tolerance during extreme exertion — but the euphoric, anxiolytic “high” experience appears to be primarily an endocannabinoid phenomenon.

Pre-Workout Cannabis Use: What the Data Shows

A 2019 University of Colorado study (Bidwell et al., published in Frontiers in Public Health) surveyed 605 cannabis users in legal states about their pre/post-workout cannabis habits. Key findings:

• 81% reported using cannabis within one hour before exercise at least some of the time
• Of those who used before exercise, 70% reported that cannabis improved recovery
• 78% said cannabis increased enjoyment of exercise
• 52% said cannabis increased motivation to exercise
• Those who used cannabis before exercise had a higher average BMI and performed similarly on most objective metrics, but subjectively reported the experience as more enjoyable

Importantly, this is self-reported data from cannabis users who chose to use before exercise — a population pre-selected for positive cannabis-exercise associations. The data does not establish that cannabis makes exercise objectively better; it establishes that many cannabis users subjectively experience it that way.

THC and Cardiovascular Response

THC reliably increases heart rate. In healthy adults, THC produces a tachycardia response of 20–100% above baseline within minutes of use, peaking at 10–30 minutes and returning to baseline over 2–3 hours. This is mediated through CB1 receptor activation in the cardiac conduction system and sympathetic nervous system stimulation.

During exercise, this creates a compounding effect: your heart is already elevated from exertion, and THC adds further elevation. For healthy young athletes, this is unlikely to create serious risk. For individuals with cardiovascular conditions — particularly hypertension, arrhythmia, or history of cardiac events — combining THC with intense exercise carries meaningful risk. The American Heart Association has specifically cautioned against cannabis use around exercise for people with cardiovascular disease.

Bronchodilation Effect

Cannabis smoke (and to a lesser degree vapor) produces acute bronchodilation — a widening of the airways that is the opposite of the bronchoconstriction seen in asthma. This has been documented since the 1970s and was one of the early proposed medical applications of cannabis for asthma.

The bronchodilation is mediated through CB1 receptor activation in bronchial smooth muscle, producing relaxation. In theory, this could benefit exercise by improving airflow. In practice:

• The effect lasts only 15–20 minutes after smoking and is difficult to time usefully
• Smoking cannabis produces combustion byproducts (tar, carbon monoxide) that simultaneously damage lung tissue — negating any bronchodilation benefit with chronic use
• Vaporization at controlled temperatures (170–185°C) produces bronchodilation without combustion products and is increasingly the delivery method of choice for athletic cannabis users
• No clinical study has demonstrated improved exercise capacity from cannabis-induced bronchodilation in humans

Anti-Doping Rules by Sport

CBD for Exercise Recovery: Current Evidence

CBD (cannabidiol) is the cannabis compound most consistently studied for recovery applications, and the one permitted by all major sports organizations. Recovery mechanisms of interest:

• Anti-inflammatory: CBD modulates CB2 receptors and TRPV1 channels, reducing prostaglandin and cytokine production. A 2020 review in Sports Medicine found the anti-inflammatory mechanism is scientifically plausible but clinical data in athletic populations is limited.
• Sleep quality: Sleep is the most evidence-backed recovery intervention. CBD has demonstrated sleep-duration improvement in anxious patients (Shannon et al., 2019) and may reduce sleep disruption after intense training.
• DOMS (Delayed Onset Muscle Soreness): Topical CBD products are widely used for DOMS; controlled evidence is emerging. A 2021 study in the European Journal of Sport Science found oral CBD did not significantly reduce DOMS after eccentric exercise in trained males.
• Neuroprotection: Contact sports athletes (American football, rugby, MMA) have particular interest in CBD’s neuroprotective properties given the concussion risk in their sports. Pre-clinical evidence is encouraging; human clinical data is limited.

Related Guides

• Cannabinoids Explained: THC, CBD, CBG, CBN
• Cannabis and Pain Relief
• Cannabis and Sleep
• Medical Cannabis by Condition

Frequently Asked Questions